Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Mesentier Louro, Louise Alessandra ^a,b   Zaverucha Do Valle, Camila ^a,b   Da Silva, Almir Jordão ^a,b   Nascimento Dos Santos, Gabriel ^a,b   Gubert, Fernanda ^a,b   De Figueirêdo, Ana Beatriz Padilha ^a,b   Torres, Ana Luiza ^a,b   Paredes, Bruno D ^a,b   Teixeira, Camila ^a   Tovar Moll, Fernanda ^a,c   Mendez Otero, Rosalia ^a,b   Santiago, Marcelo F ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INBEB   (Brazil)

^c D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHOLERA TOXIN B SUBUNIT; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT DYE; PROTEIN TUJ1; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRANSCRIPTION FACTOR POU4F1; UNCLASSIFIED DRUG; INTERLEUKIN 1BETA; MEMBRANE ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LABELING; CELL SURVIVAL; CELL TRACKING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE INJURY; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; VITREOUS BODY; ADIPOCYTE; ANIMAL; BIOLOGICAL THERAPY; CARTILAGE CELL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; NERVE CELL; NERVE CRUSH; NERVE FIBER; NERVE REGENERATION; OPTIC NERVE; OPTIC NERVE INJURIES; OSTEOCYTE;

ADIPOCYTES; ANIMALS; ANTIGENS, SURFACE; AXONS; CELL DIFFERENTIATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; CHONDROCYTES; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; IMMUNOPHENOTYPING; INTERLEUKIN-1BETA; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVE CRUSH; NERVE REGENERATION; NEURONS; OPTIC NERVE; OPTIC NERVE INJURIES; OSTEOCYTES; RATS; RETINAL GANGLION CELLS;

EID: 84908583819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110722     Document Type: Article

References (111)

1. Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Pena BN, et al. (2012) Causes of blindness and visual impairment in Latin America. Surv Ophthalmol 57: 149-177.
2. Pirouzmand F (2012) Epidemiological trends of traumatic optic nerve injuries in the largest Canadian adult trauma center. J Craniofac Surg 23: 516-520.
3. Levkovitch-Verbin H, Dardik R, Vander S, Nisgav Y, Kalev-Landoy M, et al. (2006) Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci 47: 2491-2497.
4. Horner PJ, Gage FH (2000) Regenerating the damaged central nervous system. Nature 407: 963-970.
5. Johnson EM Jr, Deckwerth TL (1993) Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 16: 31-46.
6. Fischer D, He Z, Benowitz LI (2004) Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J Neurosci 24: 1646-1651.
7. Lingor P, Teusch N, Schwarz K, Mueller R, Mack H, et al. (2007) Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J Neurochem 103: 181-189.
8. Lingor P, Tonges L, Pieper N, Bermel C, Barski E, et al. (2008) ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 131: 250-263.
9. Wong EV, David S, Jacob MH, Jay DG (2003) Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration. J Neurosci 23: 3112-3117.
10. Park KK, Liu K, Hu Y, Smith PD, Wang C, et al. (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322: 963-966.
11. Smith PD, Sun F, Park KK, Cai B, Wang C, et al. (2009) SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 64: 617-623.
12. Sun F, Park KK, Belin S, Wang D, Lu T, et al. (2011) Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480: 372-375.
13. Fischer D, Pavlidis M, Thanos S (2000) Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture. Invest Ophthalmol Vis Sci 41: 3943-3954.
14. Kurimoto T, Yin Y, Omura K, Gilbert HY, Kim D, et al. (2010) Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J Neurosci 30: 15654-15663.
15. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI (2000) Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 20: 4615-4626.
16. Yin Y, Cui Q, Gilbert HY, Yang Y, Yang Z, et al. (2009) Oncomodulin links inflammation to optic nerve regeneration. Proc Natl Acad Sci U S A 106: 19587-19592.
17. Yin Y, Cui Q, Li Y, Irwin N, Fischer D, et al. (2003) Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci 23: 2284-2293.
18. Yin Y, Henzl MT, Lorber B, Nakazawa T, Thomas TT, et al. (2006) Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci 9: 843-852.
19. Leibinger M, Muller A, Andreadaki A, Hauk TG, Kirsch M, et al. (2009) Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci 29: 14334-14341.
20. Muller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D (2009) Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol Cell Neurosci 41: 233-246.
21. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, et al. (2009) KLF family members regulate intrinsic axon regeneration ability. Science 326: 298-301.
22. Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, et al. (2010) Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci 51: 2051-2059.
23. Zaverucha-do-Valle C, Gubert F, Bargas-Rega M, Coronel JL, Mesentier-Louro LA, et al. (2011) Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat. Cell Transplant 20: 391-406.
24. Levkovitch-Verbin H, Sadan O, Vander S, Rosner M, Barhum Y, et al. (2010) Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci 51: 6394-6400.
25. de Lima S, Habboub G, Benowitz LI (2012) Combinatorial therapy stimulates long-distance regeneration, target reinnervation, and partial recovery of vision after optic nerve injury in mice. Int Rev Neurobiol 106: 153-172.
26. Parrilla-Reverter G, Agudo M, Sobrado-Calvo P, Salinas-Navarro M, Villegas-Perez MP, et al. (2009) Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp Eye Res 89: 32-41.
27. Cen LP, Luo JM, Geng Y, Zhang M, Pang CP, et al. (2012) Long-term survival and axonal regeneration of retinal ganglion cells after optic nerve transection and a peripheral nerve graft. Neuroreport 23: 692-697.
28. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG (2006) Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198: 54-64.
29. Uccelli A, Pistoia V, Moretta L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28: 219-226.
30. Heile AM, Wallrapp C, Klinge PM, Samii A, Kassem M, et al. (2009) Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett 463: 176-181.
31. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596.
32. Parr AM, Tator CH, Keating A (2007) Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40: 609-619.
33. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, et al. (2010) Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30: 140-149.
34. de Vasconcelos Dos Santos A, da Costa Reis J, Diaz Paredes B, Moraes L, Jasmin, et al. (2010) Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 1306: 149-158.
35. Giraldi-Guimaraes A, Rezende-Lima M, Bruno FP, Mendez-Otero R (2009) Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res.
36. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, et al. (2008) Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 105: 14638-14643.
37. Yoshihara T, Ohta M, Itokazu Y, Matsumoto N, Dezawa M, et al. (2007) Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury. J Neurotrauma 24: 1026-1036.
38. Ribeiro-Resende VT, Pimentel-Coelho PM, Mesentier-Louro LA, Mendez RM, Mello-Silva JP, et al. (2009) Trophic activity derived from bone marrow mononuclear cells increases peripheral nerve regeneration by acting on both neuronal and glial cell populations. Neuroscience 159: 540-549.
39. Mesentier-Louro LA, Coronel J, Zaverucha-do-Valle C, Mencalha A, Paredes BD, et al. (2012) Cell therapy modulates expression of Tax1-binding protein 1 and synaptotagmin IV in a model of optic nerve lesion. Invest Ophthalmol Vis Sci 53: 4720-4729.
40. Barbosa da Fonseca LM, Gutfilen B, Rosado de Castro PH, Battistella V, Goldenberg RC, et al. (2010) Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp Neurol 221: 122-128.
41. Yanai A, Hafeli UO, Metcalfe AL, Soema P, Addo L, et al. (2012) Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles. Cell Transplant 21: 1137-1148.
42. Yu S, Tanabe T, Dezawa M, Ishikawa H, Yoshimura N (2006) Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem Biophys Res Commun 344: 1071-1079.
43. Li N, Li XR, Yuan JQ (2009) Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch Clin Exp Ophthalmol 247: 503-514.
44. Johnson TV, Bull ND, Martin KR (2010) Identification of barriers to retinal engraftment of transplanted stem cells. Invest Ophthalmol Vis Sci 51: 960-970.
45. Jasmin, Torres AL, Nunes HM, Passipieri JA, Jelicks LA, et al. (2011) Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology 9: 4.
46. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
47. Cui Q, Yip HK, Zhao RC, So KF, Harvey AR (2003) Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neurosci 22: 49-61.
48. Xiang M, Zhou L, Macke JP, Yoshioka T, Hendry SH, et al. (1995) The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci 15: 4762-4785.
49. Nadal-Nicolas FM, Jimenez-Lopez M, Salinas-Navarro M, Sobrado-Calvo P, Alburquerque-Bejar JJ, et al. (2012) Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS One 7: e49830.
50. Sanchez-Migallon MC, Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Vidal-Sanz M, et al. (2011) Brain derived neurotrophic factor maintains Brn3a expression in axotomized rat retinal ganglion cells. Exp Eye Res 92: 260-267.
51. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, et al. (2009) Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci 50: 3860-3868.
52. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ (1994) Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 14: 4368-4374.
53. Magharious M, D'Onofrio PM, Hollander A, Zhu P, Chen J, et al. (2011) Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush. J Proteome Res 10: 3344-3362.
54. Isenmann S, Wahl C, Krajewski S, Reed JC, Bahr M (1997) Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci 9: 1763-1772.
55. Kermer P, Klocker N, Labes M, Thomsen S, Srinivasan A, et al. (1999) Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo. FEBS Lett 453: 361-364.
56. Kermer P, Ankerhold R, Klocker N, Krajewski S, Reed JC, et al. (2000) Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 85: 144-150.
57. Bahr M (2000) Live or let die - retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci 23: 483-490.
58. Kikuchi M, Tenneti L, Lipton SA (2000) Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci 20: 5037-5044.
59. Benowitz L, Yin Y (2008) Rewiring the injured CNS: lessons from the optic nerve. Exp Neurol 209: 389-398.
60. Levkovitch-Verbin H (2004) Animal models of optic nerve diseases. Eye (Lond) 18: 1066-1074.
61. Smith JN, Calvi LM (2013) Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 31: 1044-1050.
62. Laroni A, Novi G, Kerlero de Rosbo N, Uccelli A (2013) Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System. J Neuroimmune Pharmacol.
63. Zhao CP, Zhang C, Zhou SN, Xie YM, Wang YH, et al. (2007) Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy 9: 414-426.
64. Uccelli A, Milanese M, Principato MC, Morando S, Bonifacino T, et al. (2012) Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis. Mol Med 18: 794-804.
65. Lee JK, Jin HK, Bae JS (2009) Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci Lett 450: 136-141.
66. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, et al. (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28: 329-343.
67. Lu L, Zhao C, Liu Y, Sun X, Duan C, et al. (2005) Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Brain Res Protoc 15: 46-51.
68. Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WE (2011) Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 29: 169-178.
69. Li Y, Chen J, Chen XG, Wang L, Gautam SC, et al. (2002) Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514-523.
70. Rosado-de-Castro PH, Pimentel-Coelho PM, Barbosa da Fonseca LM, de Freitas GR, Mendez-Otero R (2013) The Rise of Cell Therapy Trials for Stroke: Review of Published and Registered Studies. Stem Cells Dev.
71. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761.
72. Karussis D, Kassis I, Kurkalli BG, Slavin S (2008) Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 265: 131-135.
73. Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, et al. (2008) Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 16: 2002-2010.
74. Kim H, Kim HY, Choi MR, Hwang S, Nam KH, et al. (2010) Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 468: 190-194.
75. Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, et al. (2009) Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 57: 13-23.
76. Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, et al. (2010) Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 1343: 226-235.
77. Akiyama Y, Radtke C, Kocsis JD (2002) Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 22: 6623-6630.
78. Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, et al. (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15: 862-870.
79. Liu R, Zhang Z, Lu Z, Borlongan C, Pan J, et al. (2013) Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Stem Cells Dev 22: 1053-1062.
80. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, et al. (2012) Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 7: e39500.
81. Hawryluk GW, Mothe A, Wang J, Wang S, Tator C, et al. (2012) An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 21: 2222-2238.
82. Giunti D, Parodi B, Usai C, Vergani L, Casazza S, et al. (2012) Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 30: 2044-2053.
83. Lee JK, Schuchman EH, Jin HK, Bae JS (2012) Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid beta ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells 30: 1544-1555.
84. Perry VH, Walker M (1980) Amacrine cells, displaced amacrine cells and interplexiform cells in the retina of the rat. Proc R Soc Lond B Biol Sci 208: 415-431.
85. Chen X, Katakowski M, Li Y, Lu D, Wang L, et al. (2002) Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69: 687-691.
86. Chen Q, Long Y, Yuan X, Zou L, Sun J, et al. (2005) Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 80: 611-619.
87. Dreyfus H, Sahel J, Heidinger V, Mohand-Said S, Guerold B, et al. (1998) Gangliosides and neurotrophic growth factors in the retina. Molecular interactions and applications as neuroprotective agents. Ann N Y Acad Sci 845: 240-252.
88. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843.
89. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, et al. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48.
90. Kassis I, Vaknin-Dembinsky A, Karussis D (2011) Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 6: 63-68.
91. Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, et al. (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65: 753-761.
92. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, et al. (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33: 136-143.
93. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150.
94. English K (2013) Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91: 19-26.
95. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G (2008) Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14: 3574-3589.
96. Petcu EB, Kocher T, Kuhr A, Buga AM, Kloting I, et al. (2008) Mild systemic inflammation has a neuroprotective effect after stroke in rats. Curr Neurovasc Res 5: 214-223.
97. Pickering M, O'Connor JJ (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163: 339-354.
98. Lorber B, Berry M, Logan A (2005) Lens injury stimulates adult mouse retinal ganglion cell axon regeneration via both macrophage- and lens-derived factors. Eur J Neurosci 21: 2029-2034.
99. Ahmed Z, Aslam M, Lorber B, Suggate EL, Berry M, et al. (2010) Optic nerve and vitreal inflammation are both RGC neuroprotective but only the latter is RGC axogenic. Neurobiol Dis 37: 441-454.
100. Fischer D, Hauk TG, Muller A, Thanos S (2008) Crystallins of the beta/gamma-superfamily mimic the effects of lens injury and promote axon regeneration. Mol Cell Neurosci 37: 471-479.
101. Hauk TG, Leibinger M, Muller A, Andreadaki A, Knippschild U, et al. (2010) Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys. Invest Ophthalmol Vis Sci 51: 459-464.
102. Kurimoto T, Yin Y, Habboub G, Gilbert HY, Li Y, et al. (2013) Neutrophils express oncomodulin and promote optic nerve regeneration. J Neurosci 33: 14816-14824.
103. Muller A, Hauk TG, Fischer D (2007) Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation. Brain 130: 3308-3320.
104. Leibinger M, Muller A, Gobrecht P, Diekmann H, Andreadaki A, et al. (2013) Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis 4: e609.
105. Leibinger M, Andreadaki A, Diekmann H, Fischer D (2013) Neuronal STAT3 activation is essential for CNTF- and inflammatory stimulation-induced CNS axon regeneration. Cell Death Dis 4: e805.
106. Leibinger M, Andreadaki A, Fischer D (2012) Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation. Neurobiol Dis 46: 314-324.
107. Kaushik DK, Thounaojam MC, Kumawat KL, Gupta M, Basu A (2013) Interleukin-1beta orchestrates underlying inflammatory responses in microglia via Kruppel-like factor 4. J Neurochem 127: 233-244.
108. Pousset F, Dantzer R, Kelley KW, Parnet P (2000) Interleukin-1 signaling in mouse astrocytes involves Akt: a study with interleukin-4 and IL-10. Eur Cytokine Netw 11: 427-434.
109. Reddy SA, Huang JH, Liao WS (1997) Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem 272: 29167-29173.
110. Diem R, Hobom M, Grotsch P, Kramer B, Bahr M (2003) Interleukin-1 beta protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo. Mol Cell Neurosci 22: 487-500.
111. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, et al. (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19: 35-42.